GeneVentiv Therapeutics, Inc.
PrivateLast Round
Grant
Apr 16, 2024
Total Funding Raised
$4.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GeneVentiv Therapeutics, Inc. is a drug discovery company that develops gene therapies designed to treat rare genetic disorders. The company's treatments address hemophilia and Pompe disease, aiming to provide long-lasting and effective solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneVentiv Therapeutics, Inc. Comparables
Compare GeneVentiv Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASC Therapeutics | 77% | |
| Roche Holding | 71% | |
| Pfizer | 69% | |
GeneVentiv Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2024 | ||||
| Seed | Sep 1, 2022 | ||||
| Debt | Jun 8, 2022 | ||||
| Grant | Mar 16, 2022 |
GeneVentiv Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM.
- Mar 3, 2026
Monthly visitors increased 126% MoM.
GeneVentiv Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GeneVentiv Therapeutics, Inc.'s valuation, stock price, and market status.